Tubulin-IN-56
Tubulin-IN-56 is a tubulin inhibitor. Tubulin-IN-56 exerts cytotoxic effects against colon cancer cell lines (LS180, HCT116, SW620, LoVo) . Tubulin-IN-56 downregulates βIII-tubulin and upregulates βIVa-tubulin in colon cancer cell lines. Tubulin-IN-56 inhibits cell invasiveness and elevates intracellular ROS levels in colon cancer cell lines. Tubulin-IN-56 can be used for the study of colon cancer[1].
Product Specifications
UNSPSC
12352005
Target
Microtubule/Tubulin; Reactive Oxygen Species (ROS)
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Field of Research
Cancer
Smiles
O=C(c1cccc1)N[C@@H](C2=CC=CC=C2)[C@@H](O)C(O[C@H]3C[C@]4(O)C(C)(C)C([C@@H](OC(C)=O)C([C@@]5(C)C([C@@](CO6)(OC(C)=O)[C@H]6C[C@@H]5O)[C@@H]4OC(C7=CC=CC=C7)=O)=O)=C3C)=O.[][Ru][].c8cccc8
Molecular Formula
C51H55NO14Ru
Molecular Weight
1007.05
References & Citations
[1]Ciszewski WM, et al. Ruthenocenyl and 1-Adamantyl Paclitaxel Analogs Disrupt the Balance between βIII- and βIVa-Tubulin and Inhibit the Growth and Invasiveness of Colon Cancer. J Med Chem. 2025 Sep 25;68 (18) :19062-19075.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680745-500 1x 500 µL
CD45 / LCA (2B11 + PD7/26), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880460-100 1x 100 µL
CD44 Standard (156-3C11), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940149-500 1x 500 µL
CD106 / VCAM1 (1.4C3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details